XML 146 R132.htm IDEA: XBRL DOCUMENT v3.19.1

Note 28 - Segment Information - Schedule of Segment Reporting Information By Segment (Details) - EUR (€) € in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues	€ 39,183	€ 35,746	€ 35,611
Cost of sales	(22,266)	(20,938)	(19,200)
Gross profit	16,917	14,808	16,411
Research and development expenses	(4,088)	(3,881)	(3,868)
Selling and marketing expenses	(10,551)	(9,526)	(8,856)
General and administrative expenses	(3,593)	(3,428)	(3,296)
Segment operating income (loss)	(1,315)	(2,027)	392
Total Assets	48,740	46,897
Goodwill	2,412	2,412
Product [Member]
Revenues	25,070	22,580	24,045
Cost of sales	(14,053)	(13,170)	(12,288)
HIFU Treatments and Devices Leased [Member]
Revenues	5,086	5,095	4,906
Cost of sales	(2,557)	(2,667)	(2,527)
Parts and Services [Member]
Revenues	9,007	8,011	6,628
Cost of sales	(5,655)	(5,101)	(4,385)
Product and Services, Excluding Other [Member]
Revenues	39,163	35,686	35,579
Product and Service, Other [Member]
Revenues	19	60	32
High Intensity Focused Ultrasound (HIFU) [Member]
Revenues	11,044	9,513	13,819
Cost of sales	(5,312)	(4,732)	(5,710)
Gross profit	5,732	4,782	8,109
Research and development expenses	(2,394)	(2,469)	(2,452)
Selling and marketing expenses	(4,628)	(4,004)	(3,888)
General and administrative expenses	(1,036)	(1,009)	(804)
Total expenses	(8,057)	(7,482)	(7,144)
Segment operating income (loss)	(2,325)	(2,701)	964
Total Assets	13,648	11,333	11,680
Capital expenditures	1,154	1,190	1,013
Long-lived assets	2,855	2,804	1,775
Goodwill	645	645	645
High Intensity Focused Ultrasound (HIFU) [Member] | Product [Member]
Revenues	5,494	4,232	9,382
High Intensity Focused Ultrasound (HIFU) [Member] | HIFU Treatments and Devices Leased [Member]
Revenues	3,750	3,800	3,547
High Intensity Focused Ultrasound (HIFU) [Member] | Parts and Services [Member]
Revenues	1,780	1,445	862
High Intensity Focused Ultrasound (HIFU) [Member] | Product and Services, Excluding Other [Member]
Revenues	11,025	9,477	13,791
High Intensity Focused Ultrasound (HIFU) [Member] | Product and Service, Other [Member]
Revenues	19	36	28
Urology Devices and Services (UDS) [Member]
Revenues	28,139	26,233	21,792
Cost of sales	(16,954)	(16,207)	(13,490)
Gross profit	11,185	10,026	8,302
Research and development expenses	(1,694)	(1,413)	(1,416)
Selling and marketing expenses	(5,923)	(5,521)	(4,968)
General and administrative expenses	(1,311)	(1,057)	(1,177)
Total expenses	(8,928)	(7,991)	(7,560)
Segment operating income (loss)	2,257	2,035	742
Total Assets	29,849	27,803	24,202
Capital expenditures	775	928	608
Long-lived assets	5,158	4,278	3,812
Goodwill	1,767	1,767	1,767
Urology Devices and Services (UDS) [Member] | Product [Member]
Revenues	19,576	18,348	14,664
Urology Devices and Services (UDS) [Member] | HIFU Treatments and Devices Leased [Member]
Revenues	1,336	1,295	1,359
Urology Devices and Services (UDS) [Member] | Parts and Services [Member]
Revenues	7,227	6,566	5,766
Urology Devices and Services (UDS) [Member] | Product and Services, Excluding Other [Member]
Revenues	28,139	26,209	21,789
Urology Devices and Services (UDS) [Member] | Product and Service, Other [Member]
Revenues		24	4
EDAP Technomed Co Ltd. [Member]
Revenues
Cost of sales
Gross profit
Research and development expenses
Selling and marketing expenses
General and administrative expenses	(1,246)	(1,362)	(1,315)
Total expenses	(1,246)	(1,362)	(1,315)
Segment operating income (loss)	(1,246)	(1,362)	(1,315)
Total Assets	5,243	7,761	10,709
Capital expenditures
Long-lived assets			192
Goodwill
EDAP Technomed Co Ltd. [Member] | Product [Member]
Revenues
EDAP Technomed Co Ltd. [Member] | HIFU Treatments and Devices Leased [Member]
Revenues
EDAP Technomed Co Ltd. [Member] | Parts and Services [Member]
Revenues
EDAP Technomed Co Ltd. [Member] | Product and Services, Excluding Other [Member]
Revenues
EDAP Technomed Co Ltd. [Member] | Product and Service, Other [Member]
Revenues
FDA [Member]
Revenues	39,183	35,746	35,611
Cost of sales	(22,266)	(20,938)	(19,200)
Gross profit	16,917	14,808	16,411
Research and development expenses	(4,088)	(3,881)	(3,868)
Selling and marketing expenses	(10,551)	(9,526)	(8,856)
General and administrative expenses	(3,593)	(3,428)	(3,296)
Total expenses	(18,232)	(16,835)	(16,019)
Segment operating income (loss)	(1,315)	(2,027)	392
Total Assets	48,740	46,897	46,591
Capital expenditures	1,928	2,118	1,621
Long-lived assets	8,013	7,082	5,779
Goodwill	2,412	2,412	2,412
FDA [Member] | Product [Member]
Revenues	25,070	22,580	24,045
FDA [Member] | HIFU Treatments and Devices Leased [Member]
Revenues	5,086	5,095	4,906
FDA [Member] | Parts and Services [Member]
Revenues	9,007	8,011	6,628
FDA [Member] | Product and Services, Excluding Other [Member]
Revenues	39,163	35,686	35,579
FDA [Member] | Product and Service, Other [Member]
Revenues	€ 19	€ 60	€ 32

X

- Definition

Represents the amount of long-lived assets.

+ References

No definition available.

+ Details

Name:	edap_LongLivedAssets
Namespace Prefix:	edap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name:	us-gaap_Assets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Future cash outflow to pay for purchases of fixed assets that have occurred.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

+ Details

Name:	us-gaap_CapitalExpendituresIncurredButNotYetPaid
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

+ Details

Name:	us-gaap_CostOfRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

+ Details

Name:	us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266

+ Details

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

+ Details

Name:	us-gaap_GrossProfit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingExpenses
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The aggregate total amount of expenses directly related to the marketing or selling of products or services.

+ References

No definition available.

+ Details

Name:	us-gaap_SellingAndMarketingExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=edap_HIFUTreatmentsAndDevicesLeasedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=edap_PartsAndServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=edap_ProductAndServicesExcludingOtherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=edap_HighIntensityFocusedUltrasoundHIFUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=edap_UrologyDevicesAndServicesUDSMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=edap_EDAPTechnomedCoLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=edap_FDAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: